{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:24:32Z","timestamp":1784597072270,"version":"3.55.0"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"91","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,11,20]]},"DOI":"10.18632\/oncotarget.26332","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T13:14:15Z","timestamp":1542719655000},"page":"36256-36272","source":"Crossref","is-referenced-by-count":21,"title":["Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway"],"prefix":"10.18632","volume":"9","author":[{"given":"Janine","family":"W\u00f6rthm\u00fcller","sequence":"first","affiliation":[{"name":"Unit of Anatomy, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Blum","sequence":"additional","affiliation":[{"name":"Unit of Anatomy, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland"},{"name":"Genetica AG, 8001 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Pecze","sequence":"additional","affiliation":[{"name":"Unit of Anatomy, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Salicio","sequence":"additional","affiliation":[{"name":"Unit of Anatomy, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Schwaller","sequence":"additional","affiliation":[{"name":"Unit of Anatomy, Section of Medicine, University of Fribourg, 1700 Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Yang","year":"2012","journal-title":"J Cell Physiol"},{"key":"2","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/03008200802147761","article-title":"Malignant mesothelioma\u2014a connective tissue tumor with proteoglycan-dependent differentiation","volume":"49","author":"Dobra","year":"2008","journal-title":"Connect Tissue Res"},{"key":"4","volume-title":"Pathology and genetics of tumours of the lung, pleura, thymus and heart","author":"Harris","year":"2004"},{"key":"5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0344-0338(96)80208-1","article-title":"The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type","volume":"192","author":"Celio","year":"1996","journal-title":"Pathol Res Pract"},{"key":"6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/00000478-199609000-00001","article-title":"Calretinin: a novel immunocytochemical marker for mesothelioma","volume":"20","author":"Viale","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"7","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/ijc.28218","article-title":"Calretinin is essential for mesothelioma cell growth\/survival: a potential new target for malignant mesothelioma therapy?","volume":"133","author":"Schwaller","year":"2013","journal-title":"Int J Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.2353\/ajpath.2009.080352","article-title":"SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis","volume":"174","author":"Schwaller","year":"2009","journal-title":"Am J Pathol"},{"key":"9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbaexp.2004.01.004","article-title":"Calretinin gene promoter activity is differently regulated in neurons and cancer cells. Role of AP2-like cis element and zinc ions","volume":"1678","author":"Ku\u017anicki","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10555-008-9165-4","article-title":"Signal transduction by focal adhesion kinase in cancer","volume":"28","author":"Guan","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"11","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/bjc.2014.220","article-title":"Multipoint targeting of the PI3K\/mTOR pathway in mesothelioma","volume":"110","author":"Ou","year":"2014","journal-title":"Br J Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2014.10.001","article-title":"FAK signaling in human cancer as a target for therapeutics","volume":"146","author":"Daly","year":"2015","journal-title":"Pharmacol Ther"},{"key":"13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"Sleeman","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Weinberg","year":"2009","journal-title":"J Clin Invest"},{"key":"15","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1158\/1078-0432.CCR-11-2614","article-title":"Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients","volume":"18","author":"Adusumilli","year":"2012","journal-title":"Clin Cancer Res"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.3791\/56337","article-title":"Evaluation of the Cell Invasion and Migration Process: A Comparison of the Video Microscope-based Scratch Wound Assay and the Boyden Chamber Assay","author":"Magne","year":"2017","journal-title":"J Vis Exp"},{"key":"17","first-page":"2752","article-title":"Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors","volume":"55","author":"Cance","year":"1995","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1023725029589","article-title":"FAK regulates biological processes important for the pathogenesis of cancer","volume":"22","author":"Dunty","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"19","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1200\/JCO.2011.38.9346","article-title":"Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors","volume":"30","author":"Siu","year":"2012","journal-title":"J Clin Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-07-5155","article-title":"Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271","volume":"68","author":"Martinez-Alsina","year":"2008","journal-title":"Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0006-2952(00)00427-5","article-title":"Induction and regulation of epithelial-mesenchymal transitions","volume":"60","author":"Edme","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1369\/0022155414561498","article-title":"Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights","volume":"63","author":"Lim","year":"2015","journal-title":"J Histochem Cytochem"},{"key":"23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s11626-015-9885-z","article-title":"Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line","volume":"51","author":"Schwaller","year":"2015","journal-title":"Cell Dev Biol Anim"},{"key":"24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.taap.2015.01.004","article-title":"Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells","volume":"283","author":"Ma","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Derynck","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.cr.7290318","article-title":"The interaction of versican with its binding partners","volume":"15","author":"Yang","year":"2005","journal-title":"Cell Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular changes in mesothelioma with an impact on prognosis and treatment","volume":"136","author":"Jaurand","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.mrgentox.2011.04.008","article-title":"Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells","volume":"723","author":"Zhang","year":"2011","journal-title":"Mutat Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12931-015-0311-6","article-title":"Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration","volume":"16","author":"Schwaller","year":"2015","journal-title":"Respir Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/excr.2001.5261","article-title":"Calretinin and calretinin-22k increase resistance toward sodium butyrate-induced differentiation in CaCo-2 colon adenocarcinoma cells","volume":"268","author":"Schwaller","year":"2001","journal-title":"Exp Cell Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jcb.22429","article-title":"A bipartite butyrate-responsive element in the human calretinin (CALB2) promoter acts as a repressor in colon carcinoma cells but not in mesothelioma cells","volume":"109","author":"Schwaller","year":"2010","journal-title":"J Cell Biochem"},{"key":"32","doi-asserted-by":"publisher","first-page":"21272","DOI":"10.18632\/oncotarget.7114","article-title":"Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells","volume":"7","author":"Felley-Bosco","year":"2016","journal-title":"Oncotarget"},{"key":"33","doi-asserted-by":"publisher","first-page":"9055","DOI":"10.1158\/0008-5472.CAN-07-0474","article-title":"High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif","volume":"67","author":"Kern","year":"2007","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1158\/0008-5472.CAN-05-4668","article-title":"A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent","volume":"66","author":"Lake","year":"2006","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nrm2996","article-title":"The FERM domain: organizing the structure and function of FAK","volume":"11","author":"Eck","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cancers10060196","article-title":"Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development","volume":"10","author":"Arold","year":"2018","journal-title":"Cancers (Basel)"},{"key":"37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12885-018-4385-7","article-title":"Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter","volume":"18","author":"Schwaller","year":"2018","journal-title":"BMC Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fgene.2017.00070","article-title":"Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma","volume":"8","author":"Felley-Bosco","year":"2017","journal-title":"Front Genet"},{"key":"39","doi-asserted-by":"publisher","first-page":"39766","DOI":"10.1074\/jbc.M112.406363","article-title":"Calretinin regulates Ca2+-dependent inactivation and facilitation of Ca(v)2.1 Ca2+ channels through a direct interaction with the \u03b112.1 subunit","volume":"287","author":"Lee","year":"2012","journal-title":"J Biol Chem"},{"key":"40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1471-4159.2012.07919.x","article-title":"Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity","volume":"123","author":"Wang","year":"2012","journal-title":"J Neurochem"},{"key":"41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fnana.2014.00003","article-title":"Calretinin: from a \u201csimple\u201d Ca(2+) buffer to a multifunctional protein implicated in many biological processes","volume":"8","author":"Schwaller","year":"2014","journal-title":"Front Neuroanat"},{"key":"42","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1038\/sj.onc.1204786","article-title":"Paxillin: a focal adhesion-associated adaptor protein","volume":"20","author":"Schaller","year":"2001","journal-title":"Oncogene"},{"key":"43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/1370","article-title":"Paxillin LD motifs may define a new family of protein recognition domains","volume":"5","author":"Turner","year":"1998","journal-title":"Nat Struct Biol"},{"key":"44","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1083\/jcb.135.4.1109","article-title":"Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding","volume":"135","author":"Turner","year":"1996","journal-title":"J Cell Biol"},{"key":"45","doi-asserted-by":"publisher","first-page":"36684","DOI":"10.1074\/jbc.274.51.36684","article-title":"The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin","volume":"274","author":"Schaller","year":"1999","journal-title":"J Biol Chem"},{"key":"46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2007.11.031","article-title":"Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation","volume":"29","author":"Ilic","year":"2008","journal-title":"Mol Cell"},{"key":"47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2015.09.001","article-title":"Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity","volume":"163","author":"Pachter","year":"2015","journal-title":"Cell"},{"key":"48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Schlaepfer","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Schlaepfer","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ijc.2910510220","article-title":"Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature","volume":"51","author":"Stahel","year":"1992","journal-title":"Int J Cancer"},{"key":"51","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Livak","year":"2008","journal-title":"Nat Protoc"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:57:00Z","timestamp":1720799820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":51,"journal-issue":{"issue":"91","published-print":{"date-parts":[[2018,11,20]]}},"alternative-id":["26332","30555628"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26332","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]}}}